In NSCLC lines, western blot analysis further confirmed that the expression levels of MET and p-MET decreased with knockdown of MSLN, whereas overexpression of MSLN promoted the cellular expression levels of MET and p-MET (Fig. 4D-E, Fig. S5A). The gene discussed is MET; the disease is non-small cell lung carcinoma.